In new research, Alexander Furnas, Timothy LaPira, and Clare Brock find that most politically active organizations engage in either campaign contributions or lobbying, but rarely both.The findings have implications for regulation and future academic research.
Wendy Li writes that business leaders must rediscover past unity and put pressure on politicians to defend against President Donald Trump’s attacks on businesses and civil society and prevent democratic backsliding.
Benjamin Egerod explores the information gap that prevents a majority of firms from lobbying. He argues that the lack of lobbying participation from a majority of firms creates a lopsided playing field that gives more power to those that do.
Hao Zhang examines how global value chain partnerships among large, monopolistic firms in the US enable new forms of political coordination and coalition-building to influence trade policy in their favor, despite popular backlash against globalization.
In new research, Nolan McCarty and Sepehr Shahshahani find that, contrary to the concerns of Neo-Brandeisians, Market et power does not correlate with political power via outsized lobbying.
With new limits on platforms taking effect in the EU and U.S. politicians showing greater willingness to defy tech titans, companies would do better...
Threatened by regulated price caps from congress, the pharmaceutical industry spent nearly $390 million on lobbying in 2021 according to new data from OpenSecrets.
Healthcare...